For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Philly's Context Therapeutics Will Now Test Prostate Cancer Drug on Breast Cancer

The Philadelphia Inquirer

January 15, 2018

Felix Kim, PhD, an assistant professor in the College of Medicine, was mentioned in a Jan. 15 Philadelphia Inquirer story about the sale of Argo Therapeutics to Context Therapeutics, the startup pharmaceutical company that Kim co-founded in 2015. Context is developing drugs to treat prostate and metastatic breast cancers. View Story

Topical Tags:

College of Medicine